164MO Impaired Ki67 response towards neoadjuvant endocrine therapy in luminal breast cancer is associated with mutations conferring endocrine resistance: WSG-ADAPT HR+/HER2- translational results
In: Annals of Oncology ; volume 31, page S306 ; ISSN 0923-7534, 2020
academicJournal
Zugriff:
Titel: |
164MO Impaired Ki67 response towards neoadjuvant endocrine therapy in luminal breast cancer is associated with mutations conferring endocrine resistance: WSG-ADAPT HR+/HER2- translational results
|
---|---|
Autor/in / Beteiligte Person: | Grote, I. ; Bartels, S. ; Kandt, L. ; Bollmann, L. ; Christgen, H. ; Gronewold, M. ; Gluz, O. ; Nitz, U. ; Kümmel, S. ; Braun, M. ; Aktas, B. ; Grischke, E M. ; Schumacher, C. ; Lüdtke-Heckenkamp, K. ; Kates, R. ; Wuerstlein, R. ; Gräser, M. ; Harbeck, N. ; Christgen, M. ; Kreipe, H. ; Krebshilfe, Deutsche |
Link: | |
Zeitschrift: | Annals of Oncology ; volume 31, page S306 ; ISSN 0923-7534, 2020 |
Veröffentlichung: | Elsevier BV, 2020 |
Medientyp: | academicJournal |
DOI: | 10.1016/j.annonc.2020.08.286 |
Schlagwort: |
|
Sonstiges: |
|